1. 3301 Two year estimate of overall survival in COMBI-v, a randomized, open-label, phase III study comparing the combination of dabrafenib (D) and trametinib (T) with vemurafenib (Vem) as first-line therapy in patients (pts) with unresectable or metastatic BRAF V600E/K mutation-positive cutaneous melanoma. (September 2015) Authors: Robert, C.; Karaszewska, B.; Schachter, J.; Rutkowski, P.; Mackiewicz, A.; Stroyakovskiy, D.; Lichinitser, M.; Dummer, R.; Grange, F.; Mortier, L.; Chiarion-Sileni, V.; Drucis, K.; Krajsova, I.; Hauschild, A.; Mookerjee, B.; Legos, J.; Schadendorf, D. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S663 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 3342 Assessment of quality of life using Skindex-16 in patients with advanced basal cell carcinoma (BCC) treated with vismodegib in the STEVIE study. (September 2015) Authors: Hansson, J.; Bartley, K.; Grob, J.J.; Kuntsfeld, R.; Dréno, B.; Mortier, L.; Ascierto, P.A.; Licitra, L.; Dutriaux, C.; Jouary, T.; Meyer, N.; Guillot, B.; Dummer, R.; Fife, K.; Ernst, D.S.; Yim, Y.M.; Williams, S.; Fittipaldo, A.; Basset-Seguin, N.; Hauschild, A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S680 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 3343 Exploratory analysis of vismodegib (VISMO) treatment discontinuation in the STEVIE study. (September 2015) Authors: Hauschild, A.; Hansson, J.; Grob, J.J.; Kunstfeld, R.; Dréno, B.; Mortier, L.; Ascierto, P.A.; Dummer, R.; Licitra, L.; Fife, K.; Ernst, D.S.; Dutriaux, C.; Jouary, T.; Meyer, N.; Guillot, B.; Williams, S.; Tandon, M.; Hou, J.; Basset-Seguin, N. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S681 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A new protocol using a light‐emitting fabric for PDT of AK. (1st April 2019) Authors: Vicentini, C.; Vignion‐Dewalle, A.S.; Thecua, E.; Lecomte, F.; Maire, C.; Deleporte, P.; Béhal, H.; Kerob, D.; Duhamel, A.; Mordon, S.; Mortier, L. Journal: British journal of dermatology Issue: Volume 180:Number 4(2019) Page Start: e113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Antitumor activity of ipilimumab after pembrolizumab in patients with advanced melanoma in KEYNOTE-006. (February 2017) Authors: Long, G.V.; Robert, C.; Arance, A.; Blank, C.; Ribas, A.; Lorigan, P.; Mortier, L.; Schachter, J.; Middleton, M.R.; Neyns, B.; Sznol, M.; Zhou, H.; Ebbinghaus, S.; Ibrahim, N.; Steven, N. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Characterization of patients with advanced basal cell carcinoma progressing while receiving Hedgehog pathway inhibitors. (1st March 2022) Authors: Monnet, P.; Herms, F.; Djermane, M.; Dalac, S.; Dereure, O.; Dréno, B.; Beylot‐Barry, M.; Mortier, L.; Basset‐Seguin, N. Journal: British journal of dermatology Issue: Volume 186:Number 3(2022) Page Start: 579 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Characterization of patients with advanced basal cell carcinoma progressing while receiving Hedgehog pathway inhibitors. (24th November 2021) Authors: Monnet, P.; Herms, F.; Djermane, M.; Dalac, S.; Dereure, O.; Dréno, B.; Beylot‐Barry, M.; Mortier, L.; Basset‐Seguin, N. Journal: British journal of dermatology Issue: Volume 186:Number 3(2022) Page Start: 579 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Comparison of sun protection modalities in parents and children. (February 2015) Authors: Mortier, L.; Lepesant, P.; Saiag, P.; Robert, C.; Sassolas, B.; Grange, F.; Lhomel, C.; Lebbe, C. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 29(2015)Supplement 2 Page Start: 16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Decisions to limit or withdraw treatment in young adults with melanoma. (3rd July 2017) Authors: Le Guern, A.; Touzet‐Huffman, L.; Greliak, A.; Mortier, L. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 31:Number 12(2017) Page Start: e521 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. EDIFICE Melanoma survey: knowledge and attitudes on melanoma prevention and diagnosis. (February 2015) Authors: Saiag, P.; Sassolas, B.; Mortier, L.; Grange, F.; Robert, C.; Lhomel, C.; Lebbé, C. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 29(2015)Supplement 2 Page Start: 11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗